品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
源叶 | S48495-5mg | 5mg | 厂家现货 | 56974-61-9 |
Gabexate Mesylate Gabexate Mesylate |
≥99% |
|
|
源叶 | S48494-500g | 500g | 厂家现货 | 56974-61-9 |
1-溴-2,3-二氯苯 1-Bromo-2,3-dichlorobenzene |
98% |
|
|
索莱宝 | YS146114-5g | 5g | 厂家现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|
索莱宝 | YS146114-100mg | 100mg | 厂家现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|
索莱宝 | YS146114-1g | 1g | 厂家现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|
索莱宝 | YS146114-250mg | 250mg | 厂家现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|
阿拉丁 | G129271-5mg | 5mg | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
≥99% |
|
|
阿拉丁 | G129271-25mg | 25mg | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
≥99% |
|
|
阿拉丁 | G129271-100mg | 100mg | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
≥99% |
|
|
阿拉丁 | G129271-1g | 1g | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
≥99% |
|
|
阿拉丁 | G129271-5g | 5g | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
≥99% |
|
|
阿拉丁 | G408437-1ml | 1ml | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
10mM in DMSO |
|
|
阿拉丁 | G129271-250mg | 250mg | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
≥99% |
|
|
梯希爱 | G0464-1G | 1G | 现货 | 56974-61-9 |
甲磺酸加贝酯 Gabexate Mesylate |
97.0%N |
|
|
麦克林 | G864564-5mg | 5mg | 厂家现货 | 56974-61-9 |
Gabexate Mesylate Gabexate Mesylate |
≥99% |
|
|
麦克林 | G864564-25mg | 25mg | 厂家现货 | 56974-61-9 |
Gabexate Mesylate Gabexate Mesylate |
≥99% |
|
|
麦克林 | G864564-100mg | 100mg | 厂家现货 | 56974-61-9 |
Gabexate Mesylate Gabexate Mesylate |
≥99% |
|
|
毕得 | BD131754-100mg | 100mg | 现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|
毕得 | BD131754-50mg | 50mg | 现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|
毕得 | BD131754-250mg | 250mg | 现货 | 56974-61-9 |
4-((6-胍基己基)氧基)苯甲酸乙酯甲磺酸盐 Ethyl 4-((6-guanidinohexanoy... |
98% |
|
|